Literature DB >> 28189726

Osteocalcin and its endocrine functions.

Akiko Mizokami1, Tomoyo Kawakubo-Yasukochi2, Masato Hirata3.   

Abstract

Bone has traditionally been regarded as a static structural organ that supports movement of the body and protects the internal organs. However, evidence has been accumulated in the past decade showing that bone also functions as an endocrine organ that regulates systemic glucose and energy metabolism. Osteocalcin, an osteoblast-specific secreted protein, acts as a hormone by stimulating insulin production and increasing energy expenditure and insulin sensitivity in target organs. Animal studies have shown that an increase in the circulating concentration of osteocalcin, including via exogenous application of the protein, prevents obesity and glucose intolerance. Moreover, a number of epidemiological analyses support the role of osteocalcin in the regulation of glucose and energy homeostasis in humans. Therefore, it has been suggested that osteocalcin could be a feasible preventive or therapeutic agent for metabolic disorders. In this review, we summarize the current knowledge regarding the endocrine functions of osteocalcin and its various modes of action.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocyte; Glucagon-like peptide-1; Insulin; Metabolic syndrome; Osteocalcin

Mesh:

Substances:

Year:  2017        PMID: 28189726     DOI: 10.1016/j.bcp.2017.02.001

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  47 in total

1.  Serious Hypoglycemia and Use of Warfarin in Combination With Sulfonylureas or Metformin.

Authors:  Young Hee Nam; Colleen M Brensinger; Warren B Bilker; Charles E Leonard; Xu Han; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2018-08-06       Impact factor: 6.875

Review 2.  Musculoskeletal Health in the Context of Spinal Cord Injury.

Authors:  Jillian M Clark; David M Findlay
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

3.  Smarcad1 mediates microbiota-induced inflammation in mouse and coordinates gene expression in the intestinal epithelium.

Authors:  Juri Kazakevych; Jérémy Denizot; Anke Liebert; Mariana Portovedo; Mia Mosavie; Payal Jain; Claudia Stellato; Claire Fraser; Renan Oliveira Corrêa; Marina Célestine; Raphaël Mattiuz; Hanneke Okkenhaug; J Ross Miller; Marco Aurélio Ramirez Vinolo; Marc Veldhoen; Patrick Varga-Weisz
Journal:  Genome Biol       Date:  2020-03-11       Impact factor: 13.583

4.  Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.

Authors:  D Liu; L Chen; S Dong; Z Peng; H Yang; Y Chen; L Li; H Zhou; R Zhou
Journal:  Osteoporos Int       Date:  2019-06-10       Impact factor: 4.507

5.  1α,25-Dihydroxyvitamin D3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice.

Authors:  Yi Xiong; Yixin Zhang; Na Xin; Ying Yuan; Qin Zhang; Ping Gong; Yingying Wu
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

Review 6.  Review of the Applications of Biomedical Compositions Containing Hydroxyapatite and Collagen Modified by Bioactive Components.

Authors:  Agnieszka Sobczak-Kupiec; Anna Drabczyk; Wioletta Florkiewicz; Magdalena Głąb; Sonia Kudłacik-Kramarczyk; Dagmara Słota; Agnieszka Tomala; Bożena Tyliszczak
Journal:  Materials (Basel)       Date:  2021-04-21       Impact factor: 3.623

7.  Phosphorylated PAMAM dendrimers: an analog of dentin non-collagenous proteins, enhancing the osteo/odontogenic differentiation of dental pulp stem cells.

Authors:  Jie Liu; Yuan Gao; Xiaodong Zhu; Yuerong Zhang; Hai Xu; Tianda Wang; Guangdong Zhang
Journal:  Clin Oral Investig       Date:  2021-09-13       Impact factor: 3.573

8.  Bone biomarkers in koalas: validation of assays and preliminary analyses.

Authors:  Chien-Jung Chen; Stephen T Anderson; Natasha Steiger; Allan McKinnon; Joerg Henning; Rachel Allavena
Journal:  J Vet Diagn Invest       Date:  2020-09-11       Impact factor: 1.279

9.  Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: a randomized controlled trial.

Authors:  Fatemeh Rahimi Sakak; Nazanin Moslehi; Mahtab Niroomand; Parvin Mirmiran
Journal:  Eur J Nutr       Date:  2020-11-07       Impact factor: 5.614

10.  Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients.

Authors:  Julia B Greer; Phil Greer; Bimaljit S Sandhu; Samer Alkaade; C Mel Wilcox; Michelle A Anderson; Stuart Sherman; Timothy B Gardner; Michele D Lewis; Nalini M Guda; Thiruvengadam Muniraj; Darwin Conwell; Gregory A Cote; Christopher E Forsmark; Peter A Banks; Gong Tang; Kim Stello; Andres Gelrud; Randall E Brand; Adam Slivka; David C Whitcomb; Dhiraj Yadav
Journal:  Nutr Clin Pract       Date:  2018-08-13       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.